These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 26942205
1. miRNAs in Urine Extracellular Vesicles as Predictors of Early-Stage Diabetic Nephropathy. Jia Y, Guan M, Zheng Z, Zhang Q, Tang C, Xu W, Xiao Z, Wang L, Xue Y. J Diabetes Res; 2016; 2016():7932765. PubMed ID: 26942205 [Abstract] [Full Text] [Related]
2. MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the 'Asian Indian phenotype'. Prabu P, Rome S, Sathishkumar C, Gastebois C, Meugnier E, Mohan V, Balasubramanyam M. Diabetes Metab; 2019 Jun; 45(3):276-285. PubMed ID: 30165157 [Abstract] [Full Text] [Related]
3. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy. Li Z, Xu Y, Liu X, Nie Y, Zhao Z. Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347 [Abstract] [Full Text] [Related]
4. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis. Eissa S, Matboli M, Bekhet MM. Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555 [Abstract] [Full Text] [Related]
5. Decreased Urine miR-199-3p may be a Potential Biomarker for Diabetic Nephropathy via Targeting Zinc Finger E-box-Binding Protein 1. Meng L, Li G, Liu X, Jiang J, Zhu M, Sun Y. Clin Lab; 2018 Jul 01; 64(7):1177-1182. PubMed ID: 30146830 [Abstract] [Full Text] [Related]
6. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus. Shoukry A, Bdeer Sel-A, El-Sokkary RH. Mol Cell Biochem; 2015 Oct 01; 408(1-2):25-35. PubMed ID: 26104579 [Abstract] [Full Text] [Related]
7. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients. Delić D, Eisele C, Schmid R, Baum P, Wiech F, Gerl M, Zimdahl H, Pullen SS, Urquhart R. PLoS One; 2016 Oct 01; 11(3):e0150154. PubMed ID: 26930277 [Abstract] [Full Text] [Related]
8. The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio. Ma X, Lu C, Lv C, Wu C, Wang Q. J Diabetes Res; 2016 Oct 01; 2016():6789402. PubMed ID: 26881255 [Abstract] [Full Text] [Related]
9. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy. Al-Kafaji G, Al-Muhtaresh HA. Mol Med Rep; 2018 Jul 01; 18(1):1171-1180. PubMed ID: 29845236 [Abstract] [Full Text] [Related]
10. Urinary miR-29 correlates with albuminuria and carotid intima-media thickness in type 2 diabetes patients. Peng H, Zhong M, Zhao W, Wang C, Zhang J, Liu X, Li Y, Paudel SD, Wang Q, Lou T. PLoS One; 2013 Jul 01; 8(12):e82607. PubMed ID: 24349318 [Abstract] [Full Text] [Related]
11. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus. Satirapoj B, Tassanasorn S, Charoenpitakchai M, Supasyndh O. PLoS One; 2015 Jul 01; 10(4):e0124055. PubMed ID: 25884625 [Abstract] [Full Text] [Related]
12. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy. Abdel Ghafar MT, Shalaby KH, Okda HI, Abo El Gheit RE, Soliman NA, Keshk WA. J Investig Med; 2020 Mar 01; 68(3):748-755. PubMed ID: 31722957 [Abstract] [Full Text] [Related]
13. Upregulation of miR145 and miR126 in EVs from Renal Cells Undergoing EMT and Urine of Diabetic Nephropathy Patients. Dimuccio V, Bellucci L, Genta M, Grange C, Brizzi MF, Gili M, Gallo S, Centomo ML, Collino F, Bussolati B. Int J Mol Sci; 2022 Oct 11; 23(20):. PubMed ID: 36292960 [Abstract] [Full Text] [Related]
14. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy. Ye H, Bai X, Gao H, Li L, Wu C, Sun X, Zhang C, Shen Y, Zhang J, Lu Z. J Diabetes Complications; 2014 Oct 11; 28(1):96-100. PubMed ID: 24075693 [Abstract] [Full Text] [Related]
15. Expression Profiling and Clinical Significance of Plasma MicroRNAs in Diabetic Nephropathy. Wang J, Wang G, Liang Y, Zhou X. J Diabetes Res; 2019 Oct 11; 2019():5204394. PubMed ID: 31218232 [Abstract] [Full Text] [Related]
16. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy. Lv C, Zhou YH, Wu C, Shao Y, Lu CL, Wang QY. Diabetes Metab Res Rev; 2015 Oct 11; 31(7):717-24. PubMed ID: 25952368 [Abstract] [Full Text] [Related]
17. Urinary sediment microRNAs can be used as potential noninvasive biomarkers for diagnosis, reflecting the severity and prognosis of diabetic nephropathy. Han Q, Zhang Y, Jiao T, Li Q, Ding X, Zhang D, Cai G, Zhu H. Nutr Diabetes; 2021 Jun 30; 11(1):24. PubMed ID: 34193814 [Abstract] [Full Text] [Related]
18. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin. Wu C, Wang Q, Lv C, Qin N, Lei S, Yuan Q, Wang G. Diabetes Res Clin Pract; 2014 Nov 30; 106(2):343-50. PubMed ID: 25263500 [Abstract] [Full Text] [Related]
19. Urinary miRNA-377 and miRNA-216a as biomarkers of nephropathy and subclinical atherosclerotic risk in pediatric patients with type 1 diabetes. El-Samahy MH, Adly AA, Elhenawy YI, Ismail EA, Pessar SA, Mowafy ME, Saad MS, Mohammed HH. J Diabetes Complications; 2018 Feb 30; 32(2):185-192. PubMed ID: 29175120 [Abstract] [Full Text] [Related]
20. Role of urinary podocalyxin in early diagnosis of diabetic nephropathy. Kostovska I, Trajkovska KT, Cekovska S, Topuzovska S, Kavrakova JB, Spasovski G, Kostovski O, Labudovic D. Rom J Intern Med; 2020 Dec 01; 58(4):233-241. PubMed ID: 32780718 [Abstract] [Full Text] [Related] Page: [Next] [New Search]